Empower Pharma
FDA 503B outsourcing facility
Houston, Texas
Key Takeaways
- FDA-registered 503B outsourcing facility since 2016
- Sterile compounding from bulk substances: Yes
- Last FDA inspection: November 14, 2025
- 1 FDA drug recall on record (2024)
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- July 16, 2016
- Most recent registration
- November 24, 2025
- Compounds sterile drugs from bulk substances
- Yes
- Last FDA inspection
- November 14, 2025
The FDA last inspected Empower Pharma on November 14, 2025. Investigators issued a Form FDA 483 listing inspectional observations at that visit. The FDA has not yet determined whether further action will be taken.
FDA recall history
Empower Pharma has 1 FDA drug recall on record in 2024, based on the FDA enforcement database. Breakdown: 1 Class II.
Recall reasons on record include lack of assurance of sterility.
| Date | Class | Product | Reason |
|---|---|---|---|
| September 2024 | Class II | Pyridoxine HCL (B6) Injection Solution, 100mg/mL, 30 mL Sterile Multiple-Dose Vial, For IM or IV use only, RX Only, Compounded by: Empower P | Lack of Assurance of Sterility |
FDA recall classes signal severity, not intent: Class I means a reasonable probability of serious harm, Class II a temporary or reversible risk, Class III a violation unlikely to cause harm. Sterile compounders routinely recall lots as a precaution. FDA definitions.
What this facility compounds
Empower Pharma reports compounding 29 distinct active ingredients to the FDA Outsourcing Facility Product Report (most recent reporting periods).
Tracked on PeptideGrids: Semaglutide, Glutathione, Tirzepatide, NAD+.
- 1-Testosterone
- Alpha Lipoic Acid
- Arginine Hydrochloride
- Arginine Hydrochloride; Citrulline
- Ascorbic Acid
- Biotin
- Cholecalciferol
- Cyanocobalamin; Semaglutide
- Dexpanthenol
- Estradiol Cypionate
- Glutathione
- Hydroxocobalamin
- Ketamine Hydrochloride
- Lysine Hydrochloride
- Magnesium Chloride
- Methionine; Choline Chloride
- Methionine; Choline Chloride; Cyanocobalamin
- Nandrolone Decanoate
- Niacinamide; Tirzepatide
- Nicotinamide Adenine Dinucleotide
- Pyridoxine Hydrochloride
- Semaglutide; Cyanocobalamin
- Taurine
- Testosterone
- Testosterone Cypionate
- Thiamine Hydrochloride; Niacinamide; Pyridoxine Hydrochloride; Riboflavin 5'-Phosphate Sodium; Dexpanthenol
- Tirzepatide; Niacinamide
- Ubidecarenone
- Zinc Sulfate Heptahydrate
Location
5980 W Sam Houston Pkwy N Ste 300, Houston, TX 77041-5254
Satellite and street imagery via Esri. Open larger map.
Contact
FDA-registered contact: Shaun Noorian, 877-562-8577. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of Empower Pharma with the Texas State Board of Pharmacy.
503B facilities in Texas
Texas has 16 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in Texas.
Frequently asked questions
Is Empower Pharma registered with the FDA?
Yes. Empower Pharma is a registered 503B outsourcing facility, first registered with the FDA on July 16, 2016 and most recently registered on November 24, 2025.
Has Empower Pharma been inspected by the FDA?
The FDA last inspected Empower Pharma on November 14, 2025. A Form FDA 483 was issued.
Has Empower Pharma had any FDA drug recalls?
Empower Pharma has 1 FDA drug recall on record (2024) in the FDA enforcement database.
What does Empower Pharma compound?
Empower Pharma reports compounding 29 active ingredients to the FDA, including Semaglutide, Glutathione, Tirzepatide, NAD+.
Where is Empower Pharma located?
Empower Pharma is located in Houston, Texas (5980 W Sam Houston Pkwy N Ste 300).
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026. Recall history from the FDA openFDA drug enforcement database, retrieved June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by Empower Pharma. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.